MIR3689D2

Across TCGA pan-cancer cohorts, MIR3689D2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR3689D2 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR3689D2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3689D2 expression acts as an unfavorable survival marker.

THCA, HNSC, and MESO are the cancer types where MIR3689D2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.150	0.951	<.001	108	view →
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	99	view →
MESO	OS	Tertile	All	0.074	0.565	<.001	72	view →
LGG	OS	Tertile	All	0.195	0.896	<.001	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
STAD	OS	Tertile	II,III,IV	0.175	0.660	.005	18	view →
OV	OS	Tertile	III,IV	0.362	0.836	.008	18	view →
LIHC	DFS	Tertile	All	0.093	0.543	.019	18	view →
PRAD	DFS	Tertile	All	0.107	0.886	<.001	18	view →
COAD	DFS	Tertile	All	0.194	0.688	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR3689D2–THCA (OS)

Open the THCA breakdown →